2140301-96-6 (PF-06700841 P-Tosylate | JAK,Brepocitinib P-Tosylate)

Brepocitinib tosylate;C960DPP15O;Brepocitinib tosylate [USAN];Brepocitinib tosylate (USAN);D11538;Methanone, ((1S)-2,2-difluorocyclopropyl)(3-(2-((1-methyl-1H-pyrazol-4-yl)amino)-4-pyrimidinyl)-3,8-diazabicyclo(3.2.1)oct-8-yl)-, 4-methylbenzenesulfonate (1:1);PF-06700841 P-Tosylate;Brepocitinib P-Tosylate;SCHEMBL20767478;CHEMBL5303356;[(1S)-2,2-difluorocyclopropyl]-[3-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]methanone;4-methylbenzenesulfonic acid;MS-30196;HY-112708A;Brepocitinib (P-Tosylate);((S)-2,2-difluorocyclopropyl)(3-(2-((1-methyl-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone 4-methylbenzenesulfonate;BCP29932;G15892;AC-35604;EX-A2761;DA-76777;FAKGOYNHHHOTEN-WTMFEIAXSA-N;CS-0066286;PF-06700841 Tosylate Salt;AKOS040734404;2140301-96-6;PF-06700841 tosylate?;4-{8-[(1S)-2,2-difluorocyclopropanecarbonyl]-3,8-diazabicyclo[3.2.1]octan-3-yl}-N-(1-methylpyrazol-4-yl)pyrimidin-2-amine; para-toluene sulfonate;PF-06700841 tosylate;PF-06700841 (P-Tosylate);

MFCD30480911

FAKGOYNHHHOTEN-VDTKTRGNSA-N

1S/C18H21F2N7O.C7H8O3S/c1-25-8-11(7-22-25)23-17-21-5-4-15(24-17)26-9-12-2-3-13(10-26)27(12)16(28)14-6-18(14,19)20;1-6-2-4-7(5-3-6)11(8,9)10/h4-5,7-8,12-14H,2-3,6,9-10H2,1H3,(H,21,23,24);2-5H,1H3,(H,8,9,10)/t12-,13+,14-;/m0./s1

S(C1C=CC(C)=CC=1)(=O)(=O)O.FC1(C[C@H]1C(N1[C@@H]2CN(C3C=CN=C(NC4C=NN(C)C=4)N=3)C[C@H]1CC2)=O)F